Kineon

Kineon is sold on kineon.io by Kineon, Inc. of Atlanta, Georgia, a Delaware corporation formed in September 2021 by Forrest Smith, its chief executive, and Tom Sanderson, its chief operating officer. It began as Reviiv Light, which sold the Knee+ on Indiegogo in 2021, renamed itself Kineon in 2022 and owns the KINEON trademark. Its securities filing reports 2025 sales of $6.79 million against $10.28 million in 2024.

Kineon sells one light device, the MOVE+: three battery modules on an adjustable strap, each with 8 LEDs at 660 nm and 10 class 1 laser diodes at 808 nm. It has no 510(k). Its maker, Shenzhen Kaiyan Medical Equipment, lists it with FDA as a Class II infrared therapy lamp exempt from premarket review, model XG-01B, and Kineon describes it as FDA-registered. FDA’s databases hold no Kineon recall or adverse-event report. Kineon has sold three generations of the device under the MOVE+ name and sells refurbished units on its site.

The MOVE+ is $499 on kineon.io against a compare-at price of $699, and Kineon sells it on Amazon US. It carries a 1-year warranty and a 30-day money-back guarantee for buyers who use it daily for three to four weeks. HEAL+ and CALM+ devices that Kineon crowdfunded for April 2025 delivery had not shipped by September 2026.

Trustpilot scores Kineon 4.5 from 664 reviews, 69 percent five-star and 12 percent one-star, and the BBB rates Kineon, Inc D+, not accredited, with 4 complaints in three years.